General Information of Drug Off-Target (DOT) (ID: OTVPS7S0)

DOT Name Sorting nexin-27 (SNX27)
Gene Name SNX27
Related Disease
Cone-rod dystrophy 2 ( )
Alzheimer disease ( )
Breast cancer ( )
Breast carcinoma ( )
Congenital hydrocephalus ( )
Hydrocephalus ( )
Intellectual disability ( )
Neoplasm ( )
Respiratory failure ( )
Intellectual disability, autosomal recessive 1 ( )
Invasive breast carcinoma ( )
UniProt ID
SNX27_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
4HAS; 5ZN9; 6SAK; 7CT1; 7E0B; 7P72; 7PCB
Pfam ID
PF00595 ; PF00787 ; PF00788
Sequence
MADEDGEGIHPSAPHRNGGGGGGGGSGLHCAGNGGGGGGGPRVVRIVKSESGYGFNVRGQ
VSEGGQLRSINGELYAPLQHVSAVLPGGAADRAGVRKGDRILEVNHVNVEGATHKQVVDL
IRAGEKELILTVLSVPPHEADNLDPSDDSLGQSFYDYTEKQAVPISVPRYKHVEQNGEKF
VVYNVYMAGRQLCSKRYREFAILHQNLKREFANFTFPRLPGKWPFSLSEQQLDARRRGLE
EYLEKVCSIRVIGESDIMQEFLSESDENYNGVSDVELRVALPDGTTVTVRVKKNSTTDQV
YQAIAAKVGMDSTTVNYFALFEVISHSFVRKLAPNEFPHKLYIQNYTSAVPGTCLTIRKW
LFTTEEEILLNDNDLAVTYFFHQAVDDVKKGYIKAEEKSYQLQKLYEQRKMVMYLNMLRT
CEGYNEIIFPHCACDSRRKGHVITAISITHFKLHACTEEGQLENQVIAFEWDEMQRWDTD
EEGMAFCFEYARGEKKPRWVKIFTPYFNYMHECFERVFCELKWRKENIFQMARSQQRDVA
T
Function
Involved in the retrograde transport from endosome to plasma membrane, a trafficking pathway that promotes the recycling of internalized transmembrane proteins. Following internalization, endocytosed transmembrane proteins are delivered to early endosomes and recycled to the plasma membrane instead of being degraded in lysosomes. SNX27 specifically binds and directs sorting of a subset of transmembrane proteins containing a PDZ-binding motif at the C-terminus: following interaction with target transmembrane proteins, associates with the retromer complex, preventing entry into the lysosomal pathway, and promotes retromer-tubule based plasma membrane recycling. SNX27 also binds with the WASH complex. Interacts with membranes containing phosphatidylinositol-3-phosphate (PtdIns(3P)). May participate in establishment of natural killer cell polarity. Recruits CYTIP to early endosomes.
Tissue Specificity Widely expressed. Expressed in cells of hematopoietic origin (at protein level).

Molecular Interaction Atlas (MIA) of This DOT

11 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Cone-rod dystrophy 2 DISX2RWY Definitive Altered Expression [1]
Alzheimer disease DISF8S70 Strong Biomarker [2]
Breast cancer DIS7DPX1 Strong Biomarker [3]
Breast carcinoma DIS2UE88 Strong Biomarker [3]
Congenital hydrocephalus DIS7O6UL Strong Biomarker [4]
Hydrocephalus DISIZUF7 Strong Biomarker [4]
Intellectual disability DISMBNXP Strong Biomarker [5]
Neoplasm DISZKGEW Strong Biomarker [6]
Respiratory failure DISVMYJO Strong Genetic Variation [7]
Intellectual disability, autosomal recessive 1 DISINB3A moderate Biomarker [8]
Invasive breast carcinoma DISANYTW Limited Altered Expression [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
8 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Sorting nexin-27 (SNX27). [9]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Sorting nexin-27 (SNX27). [10]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Sorting nexin-27 (SNX27). [11]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Sorting nexin-27 (SNX27). [12]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Sorting nexin-27 (SNX27). [13]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Sorting nexin-27 (SNX27). [14]
Marinol DM70IK5 Approved Marinol increases the expression of Sorting nexin-27 (SNX27). [15]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of Sorting nexin-27 (SNX27). [16]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)

References

1 Snx27 Deletion Promotes Recovery From Spinal Cord Injury by Neuroprotection and Reduces Macrophage/Microglia Proliferation.Front Neurol. 2018 Dec 13;9:1059. doi: 10.3389/fneur.2018.01059. eCollection 2018.
2 Downregulation of SNX27 expression does not exacerbate amyloidogenesis in the APP/PS1 Alzheimer's disease mouse model.Neurobiol Aging. 2019 May;77:144-153. doi: 10.1016/j.neurobiolaging.2019.01.011. Epub 2019 Jan 25.
3 SNX27-retromer assembly recycles MT1-MMP to invadopodia and promotes breast cancer metastasis.J Cell Biol. 2020 Jan 6;219(1):e201812098. doi: 10.1083/jcb.201812098.
4 SNX27 Deletion Causes Hydrocephalus by Impairing Ependymal Cell Differentiation and Ciliogenesis.J Neurosci. 2016 Dec 14;36(50):12586-12597. doi: 10.1523/JNEUROSCI.1620-16.2016.
5 Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome.Nat Med. 2013 Apr;19(4):473-80. doi: 10.1038/nm.3117. Epub 2013 Mar 24.
6 Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo.BMC Cancer. 2019 Jun 10;19(1):555. doi: 10.1186/s12885-019-5769-z.
7 Sorting nexin 27 (SNX27) variants associated with seizures, developmental delay, behavioral disturbance, and subcortical brain abnormalities.Clin Genet. 2020 Mar;97(3):437-446. doi: 10.1111/cge.13675. Epub 2019 Dec 11.
8 Systematic analysis of DNA crosslink repair pathways during development and aging in Caenorhabditis elegans.Nucleic Acids Res. 2017 Sep 19;45(16):9467-9480. doi: 10.1093/nar/gkx660.
9 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
10 Cyclosporine A--induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci. 2012 Mar;126(1):101-13.
11 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
12 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
13 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
14 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
15 Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod. 2006 May;12(5):321-33. doi: 10.1093/molehr/gal036. Epub 2006 Apr 5.
16 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.